Cynosure Group LLC acquired a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 7,090 shares of the company’s stock, valued at approximately $475,000.
Other hedge funds have also recently made changes to their positions in the company. Drummond Knight Asset Management Pty Ltd purchased a new position in shares of Corteva during the 4th quarter worth approximately $25,713,000. Alberta Investment Management Corp purchased a new position in shares of Corteva during the 3rd quarter worth approximately $5,018,000. Avior Wealth Management LLC boosted its position in Corteva by 464.7% in the 4th quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock valued at $2,205,000 after buying an additional 27,075 shares during the period. HighTower Advisors LLC boosted its position in Corteva by 8.6% in the 3rd quarter. HighTower Advisors LLC now owns 182,643 shares of the company’s stock valued at $12,352,000 after buying an additional 14,436 shares during the period. Finally, Arbejdsmarkedets Tillaegspension purchased a new position in Corteva in the 4th quarter valued at approximately $23,679,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have commented on CTVA. Rothschild & Co Redburn raised their price target on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Jefferies Financial Group raised their price target on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Mizuho raised their price target on shares of Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a research report on Wednesday, April 15th. Royal Bank Of Canada raised their price target on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Finally, Berenberg Bank raised their price target on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research report on Thursday, March 26th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $88.81.
Corteva Price Performance
Corteva stock opened at $76.84 on Wednesday. The stock has a market cap of $51.39 billion, a P/E ratio of 45.20, a price-to-earnings-growth ratio of 2.32 and a beta of 0.57. The company has a fifty day simple moving average of $80.02 and a 200-day simple moving average of $75.52. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07.
Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.
Corteva Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s payout ratio is 42.35%.
Corteva Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Stories
- Five stocks we like better than Corteva
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
